Related Experiment Video
Updated: Jul 17, 2025

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
Circadian biology to advance therapeutics for mood disorders
Apoorva Bhatnagar1, Greg Murray2, Sandipan Ray3
1Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, 502284, Telangana, India; Centre for Mental Health, Swinburne University of Technology, Melbourne, Victoria, Australia.
Abstract:
Mood disorders account for a significant global disease burden, and pharmacological innovation is needed as existing medications are suboptimal. A wide range of evidence implicates circadian and sleep dysfunction in the pathogenesis of mood disorders, and there is growing interest in these chronobiological pathways as a focus for treatment innovation. We review contemporary evidence in three promising areas in circadian-clock-based therapeutics in mood disorders: targeting the circadian system informed by mechanistic molecular advances; time-tailoring of medications; and personalizing treatment using circadian parameters. We also consider the limitations and challenges in accelerating the development of new circadian-informed pharmacotherapies for mood disorders.
Insights
New research explores circadian clock-based treatments for mood disorders, addressing suboptimal current medications. This review highlights targeting the circadian system, medication timing, and personalized approaches for better therapeutic outcomes.
Area of Science:
- Neuroscience
- Pharmacology
- Chronobiology
Background:
- Mood disorders represent a significant global health challenge with existing treatments often being suboptimal.
- Growing evidence links circadian and sleep dysfunction to the development of mood disorders.
- Chronobiological pathways are emerging as a key focus for innovative mood disorder therapeutics.
Purpose of the Study:
- To review contemporary evidence for circadian-clock-based therapeutics in mood disorders.
- To explore three promising areas: targeting the circadian system, time-tailoring medications, and personalized treatment using circadian parameters.
- To consider challenges in developing new circadian-informed pharmacotherapies.
Main Methods:
- Review of contemporary scientific literature and evidence.
- Analysis of mechanistic molecular advances related to the circadian system.
- Examination of chronobiological parameters for treatment personalization.
Main Results:
- Identification of three key areas for circadian-based therapeutics: direct circadian system targeting, chronopharmacology (time-tailoring), and personalized circadian parameter application.
- Discussion of the potential of these approaches to overcome limitations of current mood disorder treatments.
- Consideration of the scientific and developmental hurdles for these novel therapies.
Conclusions:
- Circadian clock-based strategies offer promising avenues for innovative mood disorder pharmacotherapies.
- Further research and development are needed to overcome challenges in translating these chronobiological insights into clinical practice.
- Personalized and time-tailored treatments hold potential for improved efficacy in mood disorder management.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Management of Insomnia
Biological Clocks and Seasonal Responses
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

